Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 6,946,120

« Back to Dashboard

Which drugs does patent 6,946,120 protect, and when does it expire?

Patent 6,946,120 protects MEN'S ROGAINE and WOMEN'S ROGAINE and is included in one NDA.

This patent has sixteen patent family members in eleven countries.

Summary for Patent: 6,946,120

Title: Pharmaceutical composition
Abstract:A pharmaceutical composition for topical administration, including, as the pharmaceutically active component, at least 5% by weight, based on the total weight of the composition of a piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; an acid in an amount to completely solubilise the piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; a solvent composition including at least two of water, a lower alcohol and a co-solvent selected from one or more of the group consisting of aromatic and polyhydric alcohols; wherein when the co-solvent includes propylene glycol, it is present in an amount of less than approximately 10% by weight.
Inventor(s): Wai-Chiu So; Tony (Doncaster East, AU), Deo; Peter Paul (Oakleigh, AU), Tait; Russell John (Deepdene, AU)
Assignee: Connetics Australia Pty. Ltd. (Victoria, AU)
Application Number:10/124,197
Patent Claim Types:
see list of patent claims
Formulation; Compound; Delivery; Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Johnson And Johnson
Johnson And Johnson
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,946,120

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPP 3107Apr 22, 1998

International Patent Family for Patent: 6,946,120

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria331517► Subscribe
Australia3323299► Subscribe
Australia757601► Subscribe
AustraliaPP310798► Subscribe
Brazil9909796► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.